Jiabin Liu

Jiabin Liu

Auto-generated profile, based on publicly available information

Jiabin Liu

Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623 Guangdong, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2019 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
TLTongyi Lu
Tongyi Lu
LLLi Li
Li Li
JZJinhong Zhu
Jinhong Zhu
JLJiabin Liu
Jiabin Liu
ALAo Lin
Ao Lin
Jing HeJing He
Jing He
Wilms tumor is the most common type of renal malignancy in children. Previous studies have demonstrated that single nucleotide polymorphisms (SNPs) in the AURKA gene could predispose to several human malignancies. We recruited 145 cases and 531 cancer-free controls to investigate whether AURKA gene variants modify Wilms tumor susceptibility. Three AURKA SNPs (rs1047972 C>T, rs2273535 T>A, and rs8173 G>C) were genotyped by the Taqman methodology. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of association between AURKA SNPs and Wilms tumor risk. We found that only the rs8173 G>C polymorphism was significantly associated with Wilms tumor risk (GC vs. GG: adjusted OR (AOR) = 0.50, 95% CI = 0.35–0.73, P=0.0002; GC/CC vs. GG: AOR = 0.60, 95% CI = 0.42–0.88, P=0.008). Stratification analysis revealed that rs8173 GC/CC genotypes were associated with Wilms tumor risk among children aged >18 months (AOR = 0.56, 95% CI = 0.34–0.93, P=0.024), male children (AOR = 0.54, 95% CI = 0.33–0.90, P=0.017), and children with clinical stage III + IV diseases (AOR = 0.56, 95% CI = 0.35–0.90, P=0.017). Haplotype analysis indicated that the CAG haplotype was significantly associated with increased Wilms tumor risk. In conclusion, our findings indicated that the AURKA rs8173 G>C polymorphism was associated with decreased Wilms tumor risk in Chinese children.

10 September 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
YLYong Li
Yong Li
ZZZhen-Jian Zhuo
Zhen-Jian Zhuo
HZHaiyan Zhou
Haiyan Zhou
JLJiabin Liu
Jiabin Liu
ZXZhenghui Xiao
Zhenghui Xiao
ZLZan Liu
Zan Liu
Neuroblastoma is the most common seen solid neural tumor in children less than age one. As mutation in themiR-34b/cgene is observed in several types of human malignancies, there likely to be similar events that contribute to the pathogenesis of neuroblastoma. We hypothesize that polymorphism in themiR-34b/cgene might predispose to neuroblastoma. Here, we conducted this replication study by genotyping rs4938723 T>C frommiR-34b/cin Hunan children (162 subjects with neuroblastoma and 270 control subjects) and examined its effect on the risk of neuroblastoma. We determined such association using logistic regression, adjusted for age and gender. Relative to those with TT genotype, subjects with C allele had reduced neuroblastoma risk (TC vs. TT: adjustedOR=0.46,95%CI=0.30‐0.71; additive model: adjustedOR=0.64,95%CI=0.47‐0.88; TC/CC vs. TT: adjustedOR=0.49,95%CI=0.33‐0.73). Stratified analysis revealed that rs4938723 TC/CC carriers were less likely to develop neuroblastoma for patients in the subgroups ofage≤18 months,age>18 months, females, males, tumors in retroperitoneal, tumors in other sites, and clinical stages II, III, IV, and III+IV. Our findings verifiedmiR-34b/crs4938723 C variant allele as a protective factor for the risk of neuroblastoma. Further investigation of howmiR-34b/crs4938723 T>C might modify neuroblastoma risk is warranted.

11 November 2021 in Personalized Medicine
Verified
Journal Article
Open access
JZJun Zhong
Jun Zhong
JLJiabin Liu
Jiabin Liu
YZYi Zheng
Yi Zheng
XXXiaoli Xie
Xiaoli Xie
QHQiuming He
Qiuming He
QWQiang Wu
Qiang Wu
Aim: To explore the association between miR-938 rs2505901 T>C polymorphism and Hirschsprung disease (HSCR) risk in Chinese children. Materials & Methods: We conducted a case–control study in a Chin... Lay abstract Hirschsprung disease (HSCR) is the most common intestinal disorder in infants. Genetic defects play important roles in the occurrence and development of HSCR. This case–control study w...

25 June 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JLJiabin Liu
Jiabin Liu
WJWei Jia
Wei Jia
RHRui-Xi Hua
Rui-Xi Hua
JZJinhong Zhu
Jinhong Zhu
JZJiao Zhang
Jiao Zhang
JCJiWen Cheng
JiWen Cheng
Neuroblastoma is a life-threatening extracranial solid tumor, preferentially occurring in children. However, its etiology remains unclear. APEX1 is a critical gene in the base excision repair (BER) system responsible for maintaining genome stability. Given the potential effects of APEX1 polymorphisms on the ability of the DNA damage repair, many studies have investigated the association between these variants and susceptibility to several types of cancer but not neuroblastoma. Here, we conducted a three-center case-control study to evaluate the association between APEX1 polymorphisms (rs1130409 T>G, rs1760944 T>G, and rs3136817 T>C) and neuroblastoma risk in Chinese children, consisting of 469 cases and 998 controls. Odds ratio (OR) and 95% confidence intervals (CIs) were calculated to evaluate the associations. No significant association with neuroblastoma risk was found for the studied APEX1 polymorphisms in the single locus or combination analysis. Interestingly, stratified analysis showed that rs1130409 GG genotype significantly reduced the risk of tumor in males. Furthermore, we found that carriers with 1-3 protective genotypes had a lower neuroblastoma risk in the children older than18 months and male, when compared to those without protective genotypes. In summary, our data indicate that APEX1 gene polymorphisms may have a weak effect on neuroblastoma susceptibility. These findings should be further validated by well-designed studies with larger sample size.

1 January 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
JLJiabin Liu
Jiabin Liu
RHRui-Xi Hua
Rui-Xi Hua
YCYun Cheng
Yun Cheng
JZJinhong Zhu
Jinhong Zhu
JZJiao Zhang
Jiao Zhang
Jing HeJing He
Jing He
Background: Neuroblastoma, mainly affecting children, is a lethal malignancy arising from the developing sympathetic nervous system. The genetic etiology of neuroblastoma remains mostly obscure. High mobility group AT-hook 2 (HMGA2), an oncogenic gene, is up-regulated in many tumors. Single nucleotide polymorphisms (SNPs) often modify cancer susceptibility. However, no studies are investigating the association between HMGA2 SNPs and neuroblastoma susceptibility. Methods: We conducted a four-center case-control study to evaluate the association between three HMGA2 polymorphisms (rs6581658 A>G, rs8756 A>C and rs968697 T>C) and neuroblastoma susceptibility in a Chinese population with 505 cases and 1070 controls. Logistic regression was performed to evaluate the strength of the association. Results: We found that the rs8756 AC/CC genotypes were associated with a reduced neuroblastoma risk when compared to rs8756 AA genotype [Adjusted odds ratio (OR)=0.74, 95% confidence interval (CI)=0.56– 0.99, P=0.039]. Carriers with 3 protective genotypes have lower neuroblastoma susceptibility than those without or with 0– 2 protective genotypes. The stratified analysis revealed that the protective effects of rs8756 AC/CC genotypes were more predominant among children of age > 18 months, males, and subgroups with the tumor in the mediastinum. Furthermore, haplotype analysis uncovered that haplotype ACC significantly reduced neuroblastoma risk. Conclusion: Our study indicated HMGA2 rs8756 A>C polymorphism is significantly associated with decreased neuroblastoma risk.